Related Experiment Video
Updated: Sep 11, 2025

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
Anti-cancer Drugs in Endometriosis Management: Mechanisms and Therapeutic Potential
Marzieh Neykhonji1, Abdulridha Mohammed Al-Asady2,3,4, Hanieh Akbarzadeh1
1Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Introduction:
Endometriosis is a widespread estrogen-driven condition causing pelvic pain and infertility in women. This disease shares five features with cancer: Intrinsic growth signals, insensitivity to antiproliferative signals, impaired apoptosis, induction of angiogenesis, and heightened tissue invasion, suggesting common therapeutic targets for both conditions. This article reviews studies investigating the anti-cancer drugs' protective effects and mechanisms in endometriosis treatment, providing essential insights into their efficacy and the relevant pathways in managing the disease.
Methods:
A comprehensive review was conducted to assess the potential therapeutic benefits of anti-cancer drugs in endometriosis treatment. This included an extensive search of Google Scholar and PubMed, using relevant keywords without any limitations until the end of 2024, to ensure a thorough analysis of existing research in this field.
Results:
Many drugs used in treating estrogen-dependent and other cancers have demonstrated significant therapeutic potential for endometriosis, as supported by cellular, animal, and clinical studies.
Discussion:
Though these drugs may have significant side effects, more research is necessary to determine their usefulness in endometriosis treatment. By studying various drug dosages and regimens, researchers can aim to achieve effective treatment with minimal side effects. Personalized treatment based on illness severity can be achieved by selecting the right medication and dosage.
Conclusion:
Future research can include optimizing dosages in preclinical studies, comparing repurposed drugs to conventional therapies in randomized trials, and conducting longer and larger clinical trials further to assess side effects and effectiveness in endometriosis patients.
Insights
Anti-cancer drugs show promise for treating endometriosis, a condition sharing cancer-like traits. Further research is needed to optimize dosages and minimize side effects for effective endometriosis management.
Area of Science:
- Gynecology
- Oncology
- Pharmacology
Background:
- Endometriosis is an estrogen-driven condition affecting women, causing pelvic pain and infertility.
- It shares five key features with cancer, including uncontrolled growth and tissue invasion.
- These shared characteristics suggest common therapeutic targets for both diseases.
Purpose of the Study:
- To review studies on the efficacy and mechanisms of anti-cancer drugs in treating endometriosis.
- To explore the potential of repurposed anti-cancer agents for endometriosis management.
Main Methods:
- A comprehensive literature review was performed using Google Scholar and PubMed.
- Searches included relevant keywords without date limitations up to the end of 2024.
- Existing research on anti-cancer drugs for endometriosis was thoroughly analyzed.
Main Results:
- Numerous anti-cancer drugs demonstrate significant therapeutic potential for endometriosis.
- Evidence from cellular, animal, and clinical studies supports these findings.
- These drugs target pathways relevant to endometriosis, similar to their action in cancer treatment.
Conclusions:
- Anti-cancer drugs show promise for endometriosis treatment but require further investigation.
- Research should focus on optimizing drug dosages and regimens to balance efficacy and minimize side effects.
- Personalized treatment strategies based on disease severity are crucial for effective endometriosis management.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Treatment Resistant Cancers
The Tumor Microenvironment

